BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20034464)

  • 1. Enhanced RIG-I expression is mediated by interferon regulatory factor-2 in peripheral blood B cells from hepatitis C virus-infected patients.
    Masumi A; Ito M; Mochida K; Hamaguchi I; Mizukami T; Momose H; Kuramitsu M; Tsuruhara M; Takizawa K; Kato A; Yamaguchi K
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1623-8. PubMed ID: 20034464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.
    Ito M; Masumi A; Mochida K; Kukihara H; Moriishi K; Matsuura Y; Yamaguchi K; Mizuochi T
    J Innate Immun; 2010; 2(6):607-17. PubMed ID: 20714117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.
    Cacoub P; Bourlière M; Hausfater P; Charlotte F; Khiri H; Toci S; Piette JC; Poynard T; Halfon P
    J Viral Hepat; 2003 Jan; 10(1):10-5. PubMed ID: 12558906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection.
    Wagoner J; Austin M; Green J; Imaizumi T; Casola A; Brasier A; Khabar KS; Wakita T; Gale M; Polyak SJ
    J Virol; 2007 Jan; 81(1):309-18. PubMed ID: 17035306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.
    Binder M; Kochs G; Bartenschlager R; Lohmann V
    Hepatology; 2007 Nov; 46(5):1365-74. PubMed ID: 17668876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
    Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
    J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of retinoic acid-inducible gene-I (RIG-I) expression corresponding to viral infection and UVB in human keratinocytes.
    Kimura K; Matsuzaki Y; Nishikawa Y; Kitamura H; Akasaka E; Rokunohe D; Nakano H; Imaizumi T; Satoh K; Sawamura D
    J Dermatol Sci; 2012 Apr; 66(1):64-70. PubMed ID: 22391244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells.
    Yao L; Yan X; Dong H; Nelson DR; Liu C; Li X
    Virol J; 2011 Sep; 8():445. PubMed ID: 21936899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers.
    Vilasco M; Larrea E; Vitour D; Dabo S; Breiman A; Regnault B; Riezu JI; Eid P; Prieto J; Meurs EF
    Hepatology; 2006 Dec; 44(6):1635-47. PubMed ID: 17133498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients.
    Ito M; Murakami K; Suzuki T; Mochida K; Suzuki M; Ikebuchi K; Yamaguchi K; Mizuochi T
    Clin Immunol; 2010 Jun; 135(3):459-65. PubMed ID: 20189883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
    D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
    J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Interferon Regulatory Factor 2 Gene Expression is Induced in Chronic Hepatitis C Virus Infection-A Possible Mode of Viral Persistence.
    Mukherjee RM; Bansode B; Gangwal P; Jakkampudi A; Reddy PB; Rao PN; Gupta R; Nageshwar Reddy D
    J Clin Exp Hepatol; 2012 Mar; 2(1):27-34. PubMed ID: 25755403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression.
    Su ZZ; Sarkar D; Emdad L; Barral PM; Fisher PB
    J Cell Physiol; 2007 Nov; 213(2):502-10. PubMed ID: 17516545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt.
    Farawela H; Khorshied M; Shaheen I; Gouda H; Nasef A; Abulata N; Mahmoud HA; Zawam HM; Mousa SM
    Infect Genet Evol; 2012 Aug; 12(6):1189-94. PubMed ID: 22522002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes.
    Larrea E; Riezu-Boj JI; Aldabe R; Guembe L; Echeverria I; Balasiddaiah A; Gastaminza P; Civeira MP; Sarobe P; Prieto J
    Gut; 2014 Apr; 63(4):665-73. PubMed ID: 23787026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling.
    Samanta M; Iwakiri D; Takada K
    Oncogene; 2008 Jul; 27(30):4150-60. PubMed ID: 18362887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
    Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
    Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment.
    Chen L; Sun J; Meng L; Heathcote J; Edwards AM; McGilvray ID
    J Gen Virol; 2010 Feb; 91(Pt 2):382-8. PubMed ID: 19846672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
    Dansako H; Ikeda M; Kato N
    FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.